Bookmark this page    -    Make Home Page   -    Add to del.icio.us  
Find Drug Reports                         
 

Frequently Reported Drugs
  Actonel
  Actos
  Advil
  Allegra
  Ambien
  Avandia

  Baclofen
  Boniva

  Celebrex
  Celexa
  Combivent
  Cymbalta

  Depakote
  Diovan

  Effexor
  Evista

  Femara
  Flomax
  Fosamax

  Gabapentin
  Glucophage
  Glyburide

  Hydralazine

  Insulin
  Imitrex

  Levitra
  Lexapro
  Lipitor
  Lisinopril
  Lyrica

  Metoprolol
  Mobic
  Motrin

  Naproxen
  Neurontin
  Nexium
  Norvasc

  Oxycodone

  Paxil
  Percocet
  Prednisone
  Premarin
  Propecia
  Protonix
  Prozac

  Renova

  Seroquel
  Singulair
  Tamiflu
  Topamax
  Tramadol
  Ultram
  Ultracet
  Valtrex
  Valium
  Viagra
  Vicodin
  Vioxx
  Wellbutrin
  Xanax
  Xenical
  Zoloft
  Zyrtec
ULTRACET
Total reports: 20
Reported deaths: 7      Reported hospitalizations: 4
Learn about ULTRACET serious adverse events reported to Food and Drug Administration (FDA). ……………………………………………………………………………………………… ULTRACET FDA safety alerts: No
Read More Here.

Commonly reported ULTRACET side effects: dizziness, nausea, shock, multi-organ failure, hypoaesthesia, dyspnoea, confusional state, movement disorder, judgement impaired, cardiac failure congestive, medication error.

ULTRACET Interactions with: Almagel  . Unidon  . Vioxx  . Antimodic  . Depas  . Tagatin  . Hartmann soln  . Ventus  . Galexin  . Dicknol  . Deribroin  . Stillen  . Unizyme  . Amaryl  . Synthroid  . Lisinopril  . Lipitor  . Glucosamine  . Metformin  . Aspirin  . Keppra  . Aspirin  . Keppra  . Vioxx
…………………………………………………………………………………….

Physician from UNITED STATES reported ULTRACET problem on Jan 04, 2006. Female patient, 80 years of age, was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: dizziness, fall, head injury. ULTRACET dosage: unknown. Patient recovered.

ULTRACET problem was reported by a Physician from UNITED STATES on Jan 05, 2006. Female patient was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: haemorrhagic stroke. ULTRACET dosage: unknown. Patient died on 11/22/2005.

Physician from UNITED STATES reported ULTRACET problem on Jan 31, 2006. Female patient was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant. ULTRACET dosage: unknown. Patient died on 10/07/2005.

ULTRACET problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2006. Female patient, 79 years of age, weighting 110.0 lb, was diagnosed with osteoporosis, hypothyroidism, hypertension and was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased. ULTRACET dosage: unknown. During the same period patient was treated with SYNTHROID, LISINOPRIL, LIPITOR, GLUCOSAMINE. Patient recovered.

Physician from UNITED STATES reported ULTRACET problem on Oct 04, 2005. Female patient, 69 years of age, weighting 198.4 lb, was diagnosed with osteoarthritis and was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: bacterial infection, cerebrovascular accident, diabetic neuropathy, dizziness, prescribed overdose, sensory disturbance, transient ischaemic attack. ULTRACET dosage: unknown. During the same period patient was treated with METFORMIN, VIOXX, ASPIRIN. Patient recovered.

ULTRACET problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2006. Female patient, weighting 216.0 lb, was diagnosed with pain and was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. ULTRACET dosage: unknown. Patient died on 01/26/2006.

Health Professional from UNITED STATES reported ULTRACET problem on Feb 20, 2006. Male patient was treated with ULTRACET. ULTRACET dosage: unknown. Patient died.

ULTRACET problem was reported by a Physician from KOREA, REPUBLIC OF on Feb 20, 2006. Male patient, 47 years of age, was diagnosed with post-traumatic pain, gastritis and was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: dizziness, nausea, shock. ULTRACET dosage: unknown. During the same period patient was treated with ALMAGEL, ANTIMODIC, DEPAS, TAGATIN, UNIDON. Patient was hospitalized. Patient recovered.

Physician from BRAZIL reported ULTRACET problem on Feb 21, 2006. Male patient was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: judgement impaired, movement disorder. ULTRACET dosage: unknown. Patient recovered.

ULTRACET problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2006. Female patient, weighting 216.0 lb, was diagnosed with pain and was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. ULTRACET dosage: unknown. Patient died on 01/26/2006.

Physician from BRAZIL reported ULTRACET problem on Feb 22, 2006. Male patient, 37 years of age, was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: confusional state, dizziness, judgement impaired, movement disorder. ULTRACET dosage: unknown. Patient recovered.

ULTRACET problem was reported by a Physician from KOREA, REPUBLIC OF on Mar 16, 2006. Male patient, 47 years of age, was diagnosed with post-traumatic pain, gastritis and was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: dizziness, nausea, shock. ULTRACET dosage: unknown. During the same period patient was treated with ALMAGEL, ANTIMODIC, DEPAS, TAGATIN, UNIDON. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from KOREA, REPUBLIC OF reported ULTRACET problem on Mar 21, 2006. Female patient, 28 years of age, was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: dyspnoea, headache, hypersensitivity, hypoaesthesia, musculoskeletal stiffness, nausea, vomiting. ULTRACET dosage: unknown. Patient recovered.

ULTRACET problem was reported by a Health Professional from UNITED STATES on Mar 31, 2006. Female patient, 78 years of age, weighting 180.0 lb, was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: nausea, pharmaceutical product complaint, rash. ULTRACET dosage: unknown. Patient recovered.

Physician from KOREA, REPUBLIC OF reported ULTRACET problem on Mar 28, 2006. Male patient, 47 years of age, was diagnosed with post-traumatic pain, gastritis and was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: dizziness, hypotension, nausea, shock. ULTRACET dosage: unknown. During the same period patient was treated with ALMAGEL, ANTIMODIC, DEPAS, TAGATIN, UNIDON. Patient was hospitalized. Patient recovered.

ULTRACET problem was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Mar 28, 2006. Female patient, 28 years of age, was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: dyspnoea, migraine without aura. ULTRACET dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ULTRACET problem on Apr 24, 2006. Female patient, 58 years of age, weighting 110.0 lb, was diagnosed with arthritis and was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, affect lability, aggression, amnesia, confusional state, depersonalisation, hypoaesthesia, personality change, stupor. ULTRACET dosage: unknown. Patient recovered.

ULTRACET problem was reported by a Physician from KOREA, REPUBLIC OF on July 25, 2006. Female patient, 53 years of age, was diagnosed with pain and was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: multi-organ failure. ULTRACET dosage: unknown. During the same period patient was treated with HARTMANN SOLN, VENTUS, GALEXIN, DICKNOL, DERIBROIN, STILLEN, UNIZYME, AMARYL. Patient died on 07/24/2006.

Physician from KOREA, REPUBLIC OF reported ULTRACET problem on Aug 07, 2006. Female patient, 53 years of age, was diagnosed with pain and was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: multi-organ failure. ULTRACET dosage: unknown. During the same period patient was treated with HARTMANN SOLN, VENTUS, GALEXIN, DICKNOL, DERIBROIN, STILLEN, UNIZYME, AMARYL. Patient died on 07/24/2006.

ULTRACET problem was reported by a Pharmacist from UNITED STATES on Sept 12, 2006. Female patient was treated with ULTRACET. After drug was administered, patient experienced the following problems/side effects: medication error. ULTRACET dosage: unknown. During the same period patient was treated with KEPPRA. Patient was hospitalized. Patient recovered.

…………………………………………………………………………………….

Advertisements
Enter ZIP Code:




Actonel
Actos
Advil
Allegra
Ambien
Avandia
Baclofen
Boniva
Celebrex
Celexa
Combivent
Cymbalta
Depakote
Diovan
Effexor
Evista
Femara
Flomax
Fosamax
Gabapentin
Glucophage
Glyburide
Hydralazine
Insulin
Imitrex
Levitra
Lexapro
Lipitor
Lisinopril
Lyrica
Metoprolol
Mobic
Motrin
Naproxen
Neurontin
Nexium
Norvasc
Oxycodone
Paxil
Percocet
Prednisone
Premarin
Propecia
Protonix
Prozac
Renova
Seroquel
Singulair
Tamiflu
Topamax
Tramadol
Ultram
Ultracet
Valtrex
Valium
Viagra
Vicodin
Vioxx
Wellbutrin
Xanax
Xenical
Zoloft
Zyrtec


Terms of Use   |  About Us   |  Site Map   |  Privacy Policy   |   Contact Us

Copyright 2006 by Artek LLC. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.